Chicago Partners Investment »

Nrx Pharmaceuticals shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2025-12-31 $73k 33k 2.17
2025-09-30 $126k 42k 3.00

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Dimensional Etf Trust Us Equity Market (DFUS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Enterprise Products Partners (EPD)
Ishares Tr Core S&p Mcp Etf (IJH)
Energy Transfer Com Ut Ltd Ptn (ET)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Innovator Etfs Trust Quity Managd Flr (SFLR)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Vanguard Index Fds Small Cp Etf (VB)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Chicago Partners Investment

Top funds holding Nrx Pharmaceuticals

Frigate Ventures
Vanguard Group
AdvisorShares Investments
Marshall Wace
Geode Capital Management
Renaissance Technologies
Jane Street
State Street Corporation
BlackRock
Two Sigma Investments
Susquehanna International
Global Retirement Partners
One Wealth Management Investment & Advisory Services
Chicago Partners Investment
Citadel Advisors

View all funds holding Nrx Pharmaceuticals